Dr Guillermo Vanegas, MD | |
350 30th St, 530, Oakland, CA 94609-3424 | |
(510) 629-2498 | |
(510) 835-2682 |
Full Name | Dr Guillermo Vanegas |
---|---|
Gender | Male |
Speciality | Internal Medicine - Pulmonary Disease |
Location | 350 30th St, Oakland, California |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1346336054 | NPI | - | NPPES |
7372642 | Other | AETNA | |
00C504970 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | 00C504970 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Guillermo Vanegas, MD Po Box 3145, San Ramon, CA 94583-8145 Ph: (510) 629-2498 | Dr Guillermo Vanegas, MD 350 30th St, 530, Oakland, CA 94609-3424 Ph: (510) 629-2498 |
News Archive
During the recent Atrial Fibrillation Session of the Techno College at the European Association of Cardiac Thoracic Surgeons in Geneva, Switzerland, Professor Borut Gersak, Head of Cardiac Surgery from University Medical Center in Ljubljana, Slovenia challenged his audience of more than 1,000 medical professionals to think differently about existing atrial fibrillation surgical approaches.
Sagent Pharmaceuticals, Inc. has announced U.S. Food and Drug Administration (FDA) approval of azithromycin for injection, a semi-synthetic, macrolide antibiotic that is used to treat a wide variety of bacterial infections. Sagent will offer azithromycin in a 500 mg vial for intravenous use.
A new study supports earlier estimates of the prevalence of bipolar disorder in the U.S. population, and suggests the illness may be more accurately characterized as a spectrum disorder.
Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced the completion of an $18 million Series A financing led by Adams Street Partners and Latterell Venture Partners.
Cancer therapy can be much more effective using a new way to customize nuclear medicine treatment, researchers say in the December 2014 issue of The Journal of Nuclear Medicine. The process could also be useful for other diseases that could benefit from targeted radiation.
› Verified 7 days ago
Ms. Samira Yasmeen Ahmed, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1411 E 31st St, Oakland, CA 94602 Phone: 510-437-4800 | |
Jeeven Brah, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 350 Hawthorne Ave, Room 2346, Oakland, CA 94609 Phone: 510-869-6883 | |
Sanya Wadhwa, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 300 Frank H Ogawa Plz Ste 355, Oakland, CA 94612 Phone: 510-444-3297 Fax: 510-444-6421 | |
Michael Uzoma Ohabughiro, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1411 E 31st St Fl 2, Oakland, CA 94602 Phone: 510-437-5039 Fax: 510-535-7313 | |
Lisha Lynne Wilson, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 400 29th St, Ste 501, Oakland, CA 94609 Phone: 510-268-1800 Fax: 510-268-1803 | |
Chee C. Chow, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 275 W Macarthur, Oakland, CA 94611 Phone: 510-752-1000 | |
David M. Bliss, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1950 Franklin St, Oakland, CA 94612 Phone: 510-987-1000 |